Central Bali Bahari is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 2006. Central Bali Bahari was founded by a group of visionary entrepreneurs with a mission to enhance healthcare through innovative pharmaceutical solutions. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. Central Bali Bahari operates several branches across Indonesia, with a strong presence in major cities such as Surabaya, Bandung, and Medan. The company has also expanded its operations internationally, exporting its products to several countries in Southeast Asia and beyond. The company's product portfolio includes well-known brands in the pharmaceutical industry, catering to various therapeutic areas such as cardiovascular health, diabetes management, and respiratory care. Central Bali Bahari is committed to maintaining high standards of quality and safety in its manufacturing processes, adhering to international guidelines and regulations. In addition to its core pharmaceutical business, Central Bali Bahari is actively involved in research and development, collaborating with leading research institutions and universities to drive innovation in drug development. The company is a member of several industry associations, contributing to the advancement of the pharmaceutical sector in Indonesia. Central Bali Bahari's vision is to become a leading pharmaceutical company in the region, dedicated to improving the quality of life for patients through effective and affordable healthcare solutions. The company strives to achieve this by fostering a culture of excellence, integrity, and social responsibility.
Headquarters
Intercon Plaza Blok F No. 18, RT 001 RW 009
West Jakarta; Jakarta;
Postal Code: 11630
Contact Details: Purchase the Pt Central Bali Bahari report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service